Schwarz Pharma Pays U.S. $22 Million to Settle False Claims Allegations in health care fraud qui tam case brought by Nolan & Auerbach, P.A. client

Schwarz Pharma, Inc. agreed to pay the United States $22 million to resolve False Claims Act allegations relating to the sale of two drugs that had never been FDA-approved as required by law. The United States Department of Justice (DOJ) announced the settlement in an April 20, 2010 press release.

For more information about qui tam law and health care fraud, contact Nolan & Auerbach, P.A.